# IC14 for ALS Patients Expanded Access

> **NCT04309604** · — · NO_LONGER_AVAILABLE · sponsor: **Implicit Bioscience**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** IC14

## Key facts

- **NCT ID:** NCT04309604
- **Lead sponsor:** Implicit Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309604, "IC14 for ALS Patients Expanded Access". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04309604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*